Pulmonary vascular dysfunction in metabolic syndrome

Citations Over TimeTop 19% of 2018 papers

Abstract

Metabolic syndrome is a critically important precursor to the onset of many diseases, such as cardiovascular disease, and cardiovascular disease is the leading cause of death worldwide. The primary risk factors of metabolic syndrome include hyperglycaemia, abdominal obesity, dyslipidaemia, and high blood pressure. It has been well documented that metabolic syndrome alters vascular endothelial and smooth muscle cell functions in the heart, brain, kidney and peripheral vessels. However, there is less information available regarding how metabolic syndrome can affect pulmonary vascular function and ultimately increase an individual's risk of developing various pulmonary vascular diseases, such as pulmonary hypertension. Here, we review in detail how metabolic syndrome affects pulmonary vascular function.

Related Papers

• → Abdominal obesity is essential for the risk of venous thromboembolism in the metabolic syndrome: the Tromsø study(2008)79 cited
• → Prevalence of Abdominal Obesity and Metabolic Syndrome in Children and Adolescents: A Community Based Cross-Sectional Study(2020)18 cited
• → Prevalence of the Metabolic Syndrome among Outpatients with Schizophrenia or Schizoaffective Disorder(2012)1 cited
• → Metabolic syndrome and risk of psoriasis(2019)
• → Incidence of metabolic syndrome in persons with abdominal obesity and its relation with cardiovascular disease(2007)